期刊文献+

A375细胞外信号调节激酶通路与核因子κB通路的交互作用初探 被引量:1

Cross-talk between nuclear factor-κB and extracellular signal-regulated kinase signaling pathways in A375 human melanoma cells
原文传递
导出
摘要 目的 探讨黑素瘤细胞A375细胞外信号调节激酶(ERK)通路与核因子κB(NF-κB)信号转导通路的交互作用.方法 将培养的A375细胞分为对照组、选择性ERK信号通路抑制剂U0126(10 μmol/L、5 μmol/L)处理组和选择性NF-κB通路抑制剂BMS-345541(10 μmol/L、5μmol/L)处理组,分别提取蛋白质和mRNA,用Western印迹、RT-PCR观察U0126抑制ERK通路后,NF-κB P65、p-IκBα蛋白及NF-κB P65mRNA的表达,观察BMS-345541抑制NF-κB通路后ERK1/2、p-ERK1/2蛋白及ERK1 mRNA的表达.结果 应用10 μmol/L、5μmol/L U0126抑制ERK通路后,胞核NF-κB P65蛋白表达(分别为0.60±0.04、0.56±0.06)均较对照组(1.54±0.15)减少(P<0.01),其表达量与药物浓度无显著相关性(P> 0.01);p-IκBα蛋白的表达(0.90±0.05、0.70±0.02)均较对照组(0.61±0.03)增加(P<0.01),两药物浓度组之间的表达量差异有统计学意义(P< 0.01);NF-κB P65 mRNA的表达(0.79±0.05,0.75±0.04)均较对照组(0.86±0.05)减少(P<0.01).应用10 μmol/L BMS-345541抑制NF-κB通路后,ERK1/2、p-ERK1/2蛋白及ERK1 mRNA的表达(0.73±0.07、0.75±0.09、1.51±0.02)较对照组减少(P<0.01),BMS-345541浓度为5μmol/L时,ERK1/2 、p-ERK 1/2蛋白和ERK1 mRNA的表达(0.94±0.11、0.99±0.04、1.62±0.03)较对照组的差异无统计学意义(均P>0.05).结论 NF-κB通路和ERK通路在黑素瘤A375细胞中存在交互作用. Objective To investigate the cross-talk between extracellular signal-regulated kinase (ERK) and nuclear factor κB (NF-κB) signal transduction pathways in A375 human melanoma cells.Methods Cultured A375 cells were randomly divided into 5 groups:control group receiving no treatment,two U0126 (a selective inhibitor of the ERK signaling pathway) groups treated with U0126 of 10 and 5 μmol/L,and two BMS-345541 groups treated with BMS-345541 of 10 and 5 μmol/L.After 24-hour treatment,Western blot and reverse transcription PCR were performed to measure the protein expressions of NF-κB P65,phosphorylated IκBα (p-IκBα),ERK1/2,as well as p-ERK1/2,and the mRNA expressions of NF-κB P65 and ERK1,respectively.One-way analysis of variance and least significant difference (LSD)-t test were carried out for statistical analysis.Results After 24 hours of treatment with U0126 of 10 and 5 μmol/L,a significant decrease was noted in the relative expression level of NF-κB p65 protein (0.60 ± 0.04 and 0.56 ± 0.06 vs.1.54 ± 0.15,both P< 0.01) and mRNA (0.79 ± 0.05 and 0.75 ± 0.04 vs.0.86 ± 0.05,both P < 0.01),but a statistical increase in that of p-IκBα protein (0.90 ± 0.05 and 0.70 ± 0.02 vs.0.61 ± 0.03,both P < 0.01) in the two U0126 groups compared with the control group; significant differences were observed in the expression level of p-IκBo protein (P < 0.01) but not in that of NF-κB p65 protein (P > 0.01) between the two U0126 groups.The relative expression levels of ERK1/2 and p-ERK1/2 proteins as well as ERK1 mRNA were significantly higher in the control A375 cells than those in the cells treated with BMS-345541 of 10 μmol/L (0.73 ± 0.07,0.75 ± 0.09,1.51 ± 0.02,all P < 0.01),but similar to those treated with BMS-345541 of 5 μmol/L (0.94 ± 0.11,0.99 ± 0.04,1.62 ± 0.03,all P > 0.05).Conclusion There is a cross-talk between ERK and NF-κB signal transduction pathways in A375 melanoma cells.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2014年第8期570-573,共4页 Chinese Journal of Dermatology
基金 山东省自然科学基金(ZR2010HM022) 山东省科技发展计划(2011YD18012)
关键词 黑色素瘤 NF-κB 细胞外信号调节MAP激酶类 信号转导 Melanoma NF-kappa B Extracellular signal-regulated MAP kinase Signal transducting
  • 相关文献

参考文献3

二级参考文献32

  • 1李波,冯德云,程瑞雪,孙树艳,何琼琼,胡忠良,郑晖,文继舫.丙型肝炎病毒NS3蛋白促进人源肝细胞的增殖及其相关机制研究[J].生物化学与生物物理进展,2005,32(10):991-997. 被引量:6
  • 2李印,周清华,孙芝琳,孙泽芳,王艳萍,覃扬,朱文,陈晓禾.靶向抑制ERK1/2信号传导通路对人高转移大细胞肺癌细胞株L9981恶性表型的影响[J].中国肺癌杂志,2005,8(6):504-509. 被引量:3
  • 3Roberts PJ, Der CJ. Targting the Raf-MEK-ERK mitogen-activated protein kinase for the treatment of cancer! J l. ()ncogene, 2007,26 (22) :3291 -3310. 被引量:1
  • 4Li Q, Wu J ,Zheng H ,et al. Discovery of 3-( 2-aminoethyl ) -5-( 3-phcn-yl-propylidene) -thiazolidine- 2,4-dione as a dual inhibitor of the Raf/ MEK/ERK and the PI3K/Akt signaling pathways[J]. Bioorganic & Medicinal Chemistry" Letters ,2010,20 ( 15 ) :4526 - 4530. 被引量:1
  • 5Olivier S,Robe P,Bours V. Can NF-kB be a target for novel and effi- cient anti-cancer agents ? [ J ]. Biochem Pharmacol, 2006,72 ( 9 ) : 1054 - 1068. 被引量:1
  • 6Mouawad R, Sebert M, Michels J, et al. Treatment for metastatic malig- nant melanoma:Old drugs and new strategies [ J ]. Critical Reviews in Oncology/Hematology,2010,74 ( 1 ) :27 - 39. 被引量:1
  • 7Ji Z, Flaherty KT, Tsao H, et al. Targeting the RAS pathway in melano- ma [ J ]. Trends in Molecular Medicine,2012,18 ( 1 ) :27 - 33. 被引量:1
  • 8Ji Z,Flaherty KT,Tsao H. Molecular therapeutic approaches to melano- ma [ J ]. Molecular Aspects of Medicine,2010,31 (2) : 194 - 204. 被引量:1
  • 9Fukazawa H, Noguchi K, Murakami Y, et al. Mitogen-activated protein/ extrace|lular signal- regulated kinase kinase (MEK) inhibitors restore anoikis sensilivity in human breast cancer cell lines with a constitutive- ly activated extracellular-regulated kinase (ERK) pathway [ J ]. Mol Cancer Ther,2002, l (5) : 303 - 309. 被引量:1
  • 10Lind CR, Gray CW, Person AG, et al. The mitogen-activated/extracel- lularsigrtal-regulated kinasse kinaset/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells [ J ]. Neuroscience ,2006,141 (4) : 1925 - 1933. 被引量:1

共引文献10

同被引文献23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部